A Single-Centre, Randomised, Double-Blind,Placebo-Controlled, Parallel-Group Study Assessing the Mechanism of Action of RG7118 (Proof of Mechanism) in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 04 Jan 2018
At a glance
- Drugs RG 7118 (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 04 Jan 2018 New trial record